Legal & General Group PLC Vir Biotechnology, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 258,936 shares of VIR stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
258,936
Previous 258,936 -0.0%
Holding current value
$1.92 Million
Previous $1.94 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.26 - $10.7 $17,482 - $25,765
2,408 Added 0.94%
258,936 $1.94 Million
Q2 2024

Aug 14, 2024
BUY
$7.63 - $12.66 $39,973 - $66,325
5,239 Added 2.08%
256,528 $2.28 Million
Q1 2024

May 14, 2024
BUY
$8.6 - $11.9 $57,809 - $79,991
6,722 Added 2.75%
251,289 $2.55 Million
Q4 2023

Feb 15, 2024
BUY
$7.76 - $10.29 $6,999 - $9,281
902 Added 0.37%
244,567 $2.46 Million
Q3 2023

Nov 14, 2023
BUY
$9.14 - $24.62 $143,333 - $386,090
15,682 Added 6.88%
243,665 $2.28 Million
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $134,119 - $157,763
5,781 Added 2.6%
227,983 $5.59 Million
Q1 2023

May 15, 2023
SELL
$22.26 - $30.85 $3,049 - $4,226
-137 Reduced 0.06%
222,202 $5.17 Million
Q4 2022

Feb 14, 2023
BUY
$19.96 - $28.22 $77,863 - $110,086
3,901 Added 1.79%
222,339 $5.63 Million
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $76,345 - $130,029
4,181 Added 1.95%
218,438 $4.21 Million
Q2 2022

Aug 22, 2022
BUY
$19.08 - $26.7 $3.03 Million - $4.24 Million
158,982 Added 287.62%
214,257 $5.46 Million
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $6,674 - $12,603
315 Added 0.57%
55,275 $1.42 Million
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $31,775 - $55,434
1,026 Added 1.9%
54,960 $2.3 Million
Q3 2021

Nov 15, 2021
BUY
$34.9 - $54.54 $322,964 - $504,713
9,254 Added 20.71%
53,934 $2.35 Million
Q2 2021

Aug 12, 2021
BUY
$38.75 - $51.0 $634,376 - $834,921
16,371 Added 57.83%
44,680 $2.11 Million
Q1 2021

May 17, 2021
SELL
$26.34 - $83.07 $206,795 - $652,182
-7,851 Reduced 21.71%
28,309 $1.45 Million
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $226,401 - $384,997
8,875 Added 32.53%
36,160 $967,000
Q3 2020

Nov 13, 2020
SELL
$28.28 - $53.6 $32,804 - $62,176
-1,160 Reduced 4.08%
27,285 $937,000
Q2 2020

Aug 14, 2020
BUY
$27.89 - $47.86 $761,843 - $1.31 Million
27,316 Added 2419.49%
28,445 $1.16 Million
Q1 2020

May 14, 2020
SELL
$12.04 - $60.2 $4,250 - $21,250
-353 Reduced 23.82%
1,129 $39,000
Q4 2019

Feb 13, 2020
BUY
$11.83 - $15.85 $17,532 - $23,489
1,482 New
1,482 $19,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email